PECAM1 and neoplasm: In the Py8119 and B16F10 syngeneic tumor models, we observed no major differences in the percentage of area marked by CD31 (vessel area) after a short course of E7011 treatment; that is, before treatment induced significant differences in tumor size (Fig. 6A and B; Supplementary Fig. S4A and S4B).